Expiring drug patents are continuously driving innovation, as branded firms seek out new high-margin opportunities.
Examining the patent expirations by year can indicate which pharmaceutical companies face the most peril from loss of patent protection.
This chart shows which pharmaceutical companies face the most patent expirations this year.
The drug companies facing the most patent expirations this year are:
- Allergan
- Galderma Labs Lp
- Novartis
- Purdue Pharma Lp
- Boehringer Ingelheim
- Novo
- Otsuka
- Galderma Labs
- Horizon
- Genzyme Corp
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com